Intuitive Surgical (ISRG) to Release Earnings on Tuesday

Intuitive Surgical (NASDAQ:ISRG) is expected to be posting its Q1 2026 results after the market closes on Tuesday, April 21st. Analysts expect Intuitive Surgical to post earnings of $2.08 per share and revenue of $2.6216 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, April 21, 2026 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 EPS. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $469.21 on Friday. The firm has a market capitalization of $166.63 billion, a price-to-earnings ratio of 59.47, a price-to-earnings-growth ratio of 3.58 and a beta of 1.68. Intuitive Surgical has a one year low of $427.84 and a one year high of $603.88. The business has a fifty day moving average price of $479.21 and a 200-day moving average price of $514.94.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ISRG shares. BTIG Research restated a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research note on Friday, April 10th. Sanford C. Bernstein upped their price objective on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a research note on Wednesday, March 11th. Raymond James Financial upped their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $598.36.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and research note a very large addressable market — Intuitive forecasts procedure TAM reaching ~9M by 2026, supporting a multi?year growth runway as robotics penetration remains low. ISRG’s Rising Procedure TAM With Low Penetration Backs Sustained Growth
• Positive Sentiment: Shares have rallied ahead of earnings on hopes that continued procedure growth and recent product adoption (da Vinci 5) will translate into a strong print and re?rate after a weak YTD performance. Intuitive Surgical Is Jumping 2.7% Ahead of Earnings
• Positive Sentiment: RBC Capital recently reiterated a Buy, signaling continued institutional support among several bullish analyst views on ISRG’s medium?term growth. Intuitive Surgical Receives a Buy from RBC Capital
• Neutral Sentiment: Pre?Q1 research pieces dig into Wall Street estimates for procedure growth, service revenue and systems placements — useful context but not new catalysts on their own. Seeking Clues to Intuitive Surgical Q1 Earnings
• Negative Sentiment: BTIG trimmed its price target (citing potential headwinds from the CMS FY27 payment rule), a sign that reimbursement policy risk could pressure near?term multiples. Price Target Lowered at BITG Amid CMS FY27 Payment Rule Impact
• Negative Sentiment: Recent headline risks — an FDA safety communication tied to certain stapler/reload products and a disclosed internal cybersecurity phishing incident — plus notable insider selling, are keeping a risk premium on the stock. Those issues have weighed on sentiment even absent fresh fundamental misses. Slides as Investors Refocus on Safety and Cybersecurity Overhangs

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. The trade was a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently bought and sold shares of the business. Wellington Management Group LLP increased its stake in Intuitive Surgical by 9.4% in the 4th quarter. Wellington Management Group LLP now owns 3,445,880 shares of the medical equipment provider’s stock worth $1,951,609,000 after buying an additional 294,651 shares in the last quarter. Amundi increased its stake in Intuitive Surgical by 29.7% in the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Intuitive Surgical by 1.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,554,514 shares of the medical equipment provider’s stock worth $1,446,775,000 after buying an additional 39,831 shares in the last quarter. Fayez Sarofim & Co increased its stake in Intuitive Surgical by 0.3% in the 4th quarter. Fayez Sarofim & Co now owns 1,172,526 shares of the medical equipment provider’s stock worth $664,072,000 after buying an additional 3,176 shares in the last quarter. Finally, California Public Employees Retirement System increased its stake in Intuitive Surgical by 42.7% in the 4th quarter. California Public Employees Retirement System now owns 889,727 shares of the medical equipment provider’s stock worth $503,906,000 after buying an additional 266,380 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.